scholarly article | Q13442814 |
P2093 | author name string | Xin Lu | |
Qi Cao | |||
Robert R Henry | |||
Michael J Quon | |||
Simeon I Taylor | |||
Liwu Li | |||
Theodore P Ciaraldi | |||
Dongming Zhang | |||
Zhekang Ying | |||
Helen Sun | |||
Soohyun Park Kim | |||
Xiao-Jian Sun | |||
P2860 | cites work | Inflammation and insulin resistance | Q22241893 |
Inflammatory pathways and insulin action | Q75220950 | ||
A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance | Q77652485 | ||
Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells | Q77759133 | ||
Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats | Q80175273 | ||
Toll-like receptor cross-hyporesponsiveness is functional in interleukin-1-receptor-associated kinase-1 (IRAK-1)-deficient macrophages: differential role played by IRAK-1 in regulation of tumour necrosis factor and interleukin-10 production | Q81063045 | ||
Obesity, Inflammation, and Insulin Resistance | Q22250939 | ||
Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes | Q22254159 | ||
Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells | Q24291346 | ||
Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1 | Q24304774 | ||
Role of IRS-2 in insulin and cytokine signalling | Q24337494 | ||
Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway | Q24550984 | ||
Toll-like receptor signalling | Q24570126 | ||
IL-1-induced NFkappa B and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK) | Q24635274 | ||
Mechanism of ER Stress and Inflammation for Hepatic Insulin Resistance in Obesity | Q26785412 | ||
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein | Q28116980 | ||
Inflamm-aging. An evolutionary perspective on immunosenescence | Q28141817 | ||
Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta | Q28188643 | ||
Endoplasmic reticulum stress and atherosclerosis | Q28279152 | ||
Regulation of insulin receptor substrate 1 pleckstrin homology domain by protein kinase C: role of serine 24 phosphorylation | Q28581138 | ||
Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells | Q28586458 | ||
Critical nodes in signalling pathways: insights into insulin action | Q29614735 | ||
Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function | Q29616104 | ||
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB | Q29619314 | ||
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance | Q29619774 | ||
Phosphorylation of Ser24 in the pleckstrin homology domain of insulin receptor substrate-1 by Mouse Pelle-like kinase/interleukin-1 receptor-associated kinase: cross-talk between inflammatory signaling and insulin signaling that may contribute [...] | Q31162696 | ||
Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009 | Q33880303 | ||
Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats | Q33906333 | ||
Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8 | Q34006791 | ||
X chromosome-linked IRAK-1 polymorphism is a strong predictor of multiple organ failure and mortality postinjury. | Q34158003 | ||
Overexpression of Glut4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. | Q34196736 | ||
Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes | Q34330770 | ||
Adrenergic pathway activation enhances brown adipose tissue metabolism: a [¹⁸F]FDG PET/CT study in mice | Q34375039 | ||
Free fatty acids in the presence of high glucose amplify monocyte inflammation via Toll-like receptors | Q34501763 | ||
Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis | Q34625793 | ||
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage | Q34706104 | ||
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial | Q35111527 | ||
Salsalate improves glycemia and inflammatory parameters in obese young adults | Q35580779 | ||
Regulation of insulin receptor substrate-1 in liver and muscle of animal models of insulin resistance | Q35608446 | ||
QUICKI is a useful and accurate index of insulin sensitivity | Q43881330 | ||
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle | Q43990155 | ||
Fatty acid infusion selectively impairs insulin action on Akt1 and protein kinase C lambda /zeta but not on glycogen synthase kinase-3. | Q44049215 | ||
QUICKI is a useful index of insulin sensitivity in subjects with hypertension | Q44391891 | ||
Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes: reversal with weight reduction | Q44527038 | ||
Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice | Q44631827 | ||
A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice | Q45281560 | ||
Free fatty acid impairment of nitric oxide production in endothelial cells is mediated by IKKbeta | Q45282771 | ||
Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. | Q46406338 | ||
Assessing the predictive accuracy of QUICKI as a surrogate index for insulin sensitivity using a calibration model | Q46570511 | ||
Dehydroepiandrosterone mimics acute actions of insulin to stimulate production of both nitric oxide and endothelin 1 via distinct phosphatidylinositol 3-kinase- and mitogen-activated protein kinase-dependent pathways in vascular endothelium. | Q46864603 | ||
Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants | Q47759209 | ||
Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver | Q48386175 | ||
Mammalian facilitative glucose transporters: evidence for similar substrate recognition sites in functionally monomeric proteins | Q48418596 | ||
Kinetics of GLUT1 and GLUT4 glucose transporters expressed in Xenopus oocytes. | Q49146856 | ||
Transgenic mice with muscle-specific insulin resistance develop increased adiposity, impaired glucose tolerance, and dyslipidemia. | Q51581344 | ||
Pathogenesis of Hypoglycemia in Insulinoma Patients: Suppression of Hepatic Glucose Production by Insulin | Q51655108 | ||
Repeatable noninvasive measurement of mouse myocardial glucose uptake with 18F-FDG: evaluation of tracer kinetics in a type 1 diabetes model. | Q53098477 | ||
The union of vascular and metabolic actions of insulin in sickness and in health. | Q53859168 | ||
IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. | Q54023203 | ||
Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis | Q73178283 | ||
Molecular mechanisms of insulin resistance and the role of the adipocyte | Q73318407 | ||
Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction | Q74191142 | ||
Obesity: An overview of possible role(s) of gut hormones, lipid sensing and gut microbiota | Q35873170 | ||
Metabolic stress signaling mediated by mixed-lineage kinases | Q36002831 | ||
The association between innate immunity gene (IRAK1) and C-reactive protein in the Diabetes Heart Study | Q36015656 | ||
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux | Q36430696 | ||
Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. | Q36450952 | ||
Protein kinase C-zeta phosphorylates insulin receptor substrate-1, -3, and -4 but not -2: isoform specific determinants of specificity in insulin signaling. | Q36578889 | ||
Reciprocal relationships between abnormal metabolic parameters and endothelial dysfunction. | Q36706086 | ||
Splanchnic regulation of glucose production | Q36804677 | ||
Cardiovascular actions of insulin | Q36831533 | ||
Toll-like receptor 2 mediates high-fat diet-induced impairment of vasodilator actions of insulin | Q36836199 | ||
Dehydroepiandrosterone stimulates phosphorylation of FoxO1 in vascular endothelial cells via phosphatidylinositol 3-kinase- and protein kinase A-dependent signaling pathways to regulate ET-1 synthesis and secretion | Q36944784 | ||
An integrated view of insulin resistance and endothelial dysfunction | Q37035654 | ||
Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2. | Q37174878 | ||
Signalling adaptors used by Toll-like receptors: an update. | Q37244997 | ||
IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85 | Q37276745 | ||
Diet-induced obese mice develop peripheral, but not central, resistance to leptin | Q37362925 | ||
Phosphorylation of IRS proteins Yin-Yang regulation of insulin signaling | Q37403974 | ||
TIR-containing adaptors in Toll-like receptor signalling | Q37407517 | ||
Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein | Q37417220 | ||
Sympathetic nervous activation in obesity and the metabolic syndrome--causes, consequences and therapeutic implications. | Q37695713 | ||
Muscle insulin resistance: assault by lipids, cytokines and local macrophages | Q37760003 | ||
Inflammatory signaling in skeletal muscle insulin resistance: green signal for nutritional intervention? | Q37788937 | ||
Obesity-associated insulin resistance in skeletal muscle: role of lipid accumulation and physical inactivity. | Q37845219 | ||
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? | Q37890823 | ||
Adaptive immunity in obesity and insulin resistance | Q38030832 | ||
Interleukin-6 depletion selectively improves hepatic insulin action in obesity | Q38327645 | ||
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity | Q38666958 | ||
Molecular mechanism underlying the suppression of lipid oxidation during endotoxemia | Q39471490 | ||
PKC-theta knockout mice are protected from fat-induced insulin resistance | Q39989111 | ||
PKCdelta-mediated IRS-1 Ser24 phosphorylation negatively regulates IRS-1 function | Q40232546 | ||
Nicotinamide nucleotide transhydrogenase: a key role in insulin secretion | Q40332664 | ||
Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction | Q40446857 | ||
In vivo regulation of lipolysis in humans. | Q40746005 | ||
Insulin stimulation of phosphatidylinositol 3-kinase activity and association with insulin receptor substrate 1 in liver and muscle of the intact rat. | Q41851321 | ||
Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. | Q41862776 | ||
Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice | Q42427575 | ||
Increased glucose uptake promotes oxidative stress and PKC-delta activation in adipocytes of obese, insulin-resistant mice | Q42444551 | ||
Insulin stimulates increased catalytic activity of phosphoinositide-dependent kinase-1 by a phosphorylation-dependent mechanism | Q42510563 | ||
Salsalate may have broad utility in the prevention and treatment of vascular disorders and the metabolic syndrome | Q43192053 | ||
P433 | issue | 29 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
glycobiology | Q899224 | ||
P304 | page(s) | 12339-12350 | |
P577 | publication date | 2017-06-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Deletion of interleukin 1 receptor-associated kinase 1 (Irak1) improves glucose tolerance primarily by increasing insulin sensitivity in skeletal muscle | |
P478 | volume | 292 |
Q91107161 | Cilostazol ameliorates heart failure with preserved ejection fraction and diastolic dysfunction in obese and non-obese hypertensive mice |
Q57291719 | Effect of Low-Fat Diet in Obese Mice Lacking Toll-like Receptors |
Q98303246 | IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes |
Q98778691 | Inflammation brakes mitochondrial metabolism in obesity |
Q90358686 | Inhibition of Interleukin-1 Receptor-Associated Kinases 1/4, Increases Gene Expression and Serum Level of Adiponectin in Mouse Model of Insulin Resistance |
Q57116991 | Inhibition of interleukin-1 receptor-associated kinase 1 (IRAK1) as a therapeutic strategy |
Q88924828 | MicroRNA-99a mimics inhibit M1 macrophage phenotype and adipose tissue inflammation by targeting TNFα |